HIV Researchers Slam The Scientist Who Made Genetically Engineered Babies
By Nidhi Subbaraman,
BuzzFeed
| 11. 26. 2018
“I’m angry on behalf of the genetic engineering community. I’m angry on behalf of the HIV community,” one expert said. The researchers said that existing methods already offer parents simple ways to have children without transmitting the disease.
HIV researchers are incensed that the first reported use of gene editing in human embryos was aimed at conferring HIV immunity, criticizing the move as reckless and unnecessary.
The Associated Press reported Sunday that twin girls Lulu and Nana were born after a team led by He Jiankui of the Southern University of Science and Technology in Shenzhen, China, edited their genes when they were days-old embryos. Their father reportedly had HIV, and the procedure wiped out a gene that is usually necessary for the virus to infect cells. The news, first reported by MIT Technology Review, broke before the scientist had published any of his data, and was accompanied by YouTube videos in which He described his work.
Genetics experts immediately criticized the project as premature and said it risked conferring dangerous mutations to the twins.
Adding to that chorus, HIV researchers told BuzzFeed News that such a procedure doesn’t make sense for preventing HIV. Targeting and knocking out a single gene, as He claimed to do, does not offer resistance against all strains of the virus. What’s more...
Related Articles
By Pallab Gosh and Gwyndaf Hughes, BBC News | 06.26.2025
Work has begun on a controversial project to create the building blocks of human life from scratch, in what is believed to be a world first.
The research has been taboo until now because of concerns it could lead to...
By Rhys Blakely, The Times | 06.24.2025
Scientists have created fertile mice from male genetic material alone, a breakthrough that could one day open the door to human babies who inherit their genes from two fathers.
The experiment, led by Professor Yanchang Wei at Shanghai Jiao Tong...
By Gina Kolata, The New York Times | 06.20.2025
A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need...